Pictet Asset Management (Switzerland)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $33.3M | Buy |
463,842
+460,534
| +13,922% | +$33.1M | 0.04% | 358 |
|
|
2023
Q1 | $204K | Hold |
3,308
| – | – | ﹤0.01% | 1719 |
|
|
2022
Q4 | $255K | Buy |
+3,308
| New | +$255K | ﹤0.01% | 1573 |
|
|
2022
Q3 | – | Sell |
-353,521
| Closed | -$13.5M | – | 1566 |
|
|
2022
Q2 | $13.5M | Buy |
353,521
+171,849
| +95% | +$6.58M | 0.02% | 525 |
|
|
2022
Q1 | $7.52M | Sell |
181,672
-121,159
| -40% | -$5.01M | 0.01% | 714 |
|
|
2021
Q4 | $11.4M | Buy |
+302,831
| New | +$11.4M | 0.01% | 631 |
|